Key Financial Data Of Reporting Company

Cytori Cell Research Institute,Inc. - Filing #7297366

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
91,433,000 JPY
1,560,388,000 JPY
862,531,000 JPY
Ordinary profit (loss)
-419,631,000 JPY
-906,664,000 JPY
-423,528,000 JPY
Net assets
2,338,582,000 JPY
2,795,586,000 JPY
2,213,719,000 JPY
Total assets
5,146,718,000 JPY
5,816,334,000 JPY
13,598,409,000 JPY
Basic earnings (loss) per share
-48.42
15.47
-49.65
Diluted earnings per share
15.42
Equity-to-asset ratio
0.413 xbrli:pure
0.443 xbrli:pure
0.147 xbrli:pure
Net cash provided by (used in) operating activities
-420,752,000 JPY
-1,152,230,000 JPY
-367,057,000 JPY
Net cash provided by (used in) investing activities
-4,134,000 JPY
8,689,978,000 JPY
-3,492,000 JPY
Net cash provided by (used in) financing activities
-101,591,000 JPY
-7,172,572,000 JPY
-94,430,000 JPY
Cash and cash equivalents
521,986,000 JPY
1,038,227,000 JPY
208,070,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.